Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
|Videos|November 13, 2017
What Do PBMs, Health Plans Value When Selecting a Specialty Pharmacy Partner?
Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.
Advertisement
Montanez: I think PBMs are really looking for specialty pharmacies that can be very nimble around their priorities. It varies with each payer and PBM platform. They may have a very different strategy or unique strategy that they’re looking for in 2017.
A specialty pharmacy that is very nimble around their strategies and is able to meet their value, as they define it, is very important.
Advertisement
Related to this article
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
From insurance delays to injection concerns, pharmacists can help patients navigate the first month and avoid preventable treatment interruptions.
Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association discusses pharmacists’ role in diabetes and CKD care from ASN Kidney Week 2026
Pharmacy Times featured experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
PCSK9 Inhibition Lowers LDL-C in Patients With Kidney Disease
2
Walgreens Adds Pharmacist Outreach, Coverage Help for GLP-1s
3
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
4
The Growing Role the Specialty Pharmacy Team Plays in Helping Breast Cancer Patients Navigate Treatment
5